International Journal of Diabetes and Endocrinology最新文献

筛选
英文 中文
Early improvement of HbA1c, weight and low-density lipoprotein (LDL) for Type 2 diabetes (T2D) patient by Rybelsus (oral semaglutide) Rybelsus(口服semaglutide)早期改善2型糖尿病(T2D)患者HbA1c、体重和低密度脂蛋白(LDL)
International Journal of Diabetes and Endocrinology Pub Date : 2022-06-24 DOI: 10.36266/ijed/138
{"title":"Early improvement of HbA1c, weight and low-density lipoprotein (LDL) for Type 2 diabetes (T2D) patient by Rybelsus (oral semaglutide)","authors":"","doi":"10.36266/ijed/138","DOIUrl":"https://doi.org/10.36266/ijed/138","url":null,"abstract":"","PeriodicalId":13900,"journal":{"name":"International Journal of Diabetes and Endocrinology","volume":"10 21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85716148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safer Treatment of Novel Imeglimin (Twymeeg) For Elderly Female with Type 2 Diabetes (T2D) 新型依米霉素(Twymeeg)治疗老年2型糖尿病(T2D)的安全性
International Journal of Diabetes and Endocrinology Pub Date : 2022-05-28 DOI: 10.36266/ijed/137
{"title":"Safer Treatment of Novel Imeglimin (Twymeeg) For Elderly Female with Type 2 Diabetes (T2D)","authors":"","doi":"10.36266/ijed/137","DOIUrl":"https://doi.org/10.36266/ijed/137","url":null,"abstract":"","PeriodicalId":13900,"journal":{"name":"International Journal of Diabetes and Endocrinology","volume":"91 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73727594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Obesity and elevated blood pressure among school-aged adolescents in Nigeria 尼日利亚学龄青少年的肥胖和血压升高
International Journal of Diabetes and Endocrinology Pub Date : 2022-04-30 DOI: 10.5897/jde2022.0149
Bayode Samuel Ibitoye, O. A. Abel, John Kareem Abiodun, Olakunle Salau Qasim, Opeoluwa Jegede Tolulope, Olabisi Fasoranti Ifedayo, Olumide Oluwatuyi Korede, Olasunkanmi Babalola Emmanuel, Ejiyooye Toluwalope
{"title":"Obesity and elevated blood pressure among school-aged adolescents in Nigeria","authors":"Bayode Samuel Ibitoye, O. A. Abel, John Kareem Abiodun, Olakunle Salau Qasim, Opeoluwa Jegede Tolulope, Olabisi Fasoranti Ifedayo, Olumide Oluwatuyi Korede, Olasunkanmi Babalola Emmanuel, Ejiyooye Toluwalope","doi":"10.5897/jde2022.0149","DOIUrl":"https://doi.org/10.5897/jde2022.0149","url":null,"abstract":"Obesity is associated with diverse morbidities, and elevated blood pressure has been suggested to be associated with increased body weight. This study therefore aimed to determine the relationship between obesity and elevated blood pressure among adolescent. This is a cross-sectional study. Consenting adolescents aged 10 to 18 years completed a pretested semi-structured questionnaire. Anthropometric parameters and blood pressure were measured using standard methods. Data were analysed using descriptive and inferential statistics. A total of 1000 adolescents were recruited with male to female ratio of 1:1. The mean age was 14.05±1.98 years. Early adolescence was predominant (43.3%). The prevalence of obesity was 1.3% while overweight was 4.1%. There was female preponderance for both overweight (53.7%) and obesity (53.8%). Sixty–nine (6.9%) had systolic hypertension while 50 (5.0%) had diastolic hypertension. Three (23.1%) obese and four (9.8%) overweight adolescents had statistically significant elevated systolic blood pressure in the hypertensive range (χ 2 = 11.306, p = 0.015). One (7.7%) obese and four (9.8%) overweight subjects had statistically significant elevated diastolic blood pressure (χ 2 = 9.803, p = 0.029). Routine screening for elevated blood pressure in schools is highly recommended among school-aged adolescents especially the obese and overweight. Inferential statistics was done using Chi-square and Student’s t-test for categorical and continuous variables respectively. Correlation of blood pressure with overweight and obesity was also done to know the strength of association. Logistic regression was used to examine the association between overweight and obesity and the blood pressure that were significantly associated with it. Analyses with probability value p less than 0.05 were taken as statistically significant.","PeriodicalId":13900,"journal":{"name":"International Journal of Diabetes and Endocrinology","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80040860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improved Glucose Variability of Continuous Glucose Monitoring (CGM) By Intake of Japanese Healthy Tofu as Low Carbohydrate Diet (LCD) 日本健康豆腐作为低碳水化合物饮食(LCD)改善连续血糖监测(CGM)的葡萄糖变异性
International Journal of Diabetes and Endocrinology Pub Date : 2022-04-01 DOI: 10.36266/ijed/136
{"title":"Improved Glucose Variability of Continuous Glucose Monitoring (CGM) By Intake of Japanese Healthy Tofu as Low Carbohydrate Diet (LCD)","authors":"","doi":"10.36266/ijed/136","DOIUrl":"https://doi.org/10.36266/ijed/136","url":null,"abstract":"","PeriodicalId":13900,"journal":{"name":"International Journal of Diabetes and Endocrinology","volume":"219 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79789661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Glucocorticoid Sensitivity in vitrocan predict the Clinical Response to Steroid Therapy in Children with Idiopathic Nephrotic Syndrome 体外糖皮质激素敏感性可以预测特发性肾病综合征患儿对类固醇治疗的临床反应
International Journal of Diabetes and Endocrinology Pub Date : 2022-03-07 DOI: 10.36266/ijed/132
{"title":"Glucocorticoid Sensitivity in vitrocan predict the Clinical Response to Steroid Therapy in Children with Idiopathic Nephrotic Syndrome","authors":"","doi":"10.36266/ijed/132","DOIUrl":"https://doi.org/10.36266/ijed/132","url":null,"abstract":"","PeriodicalId":13900,"journal":{"name":"International Journal of Diabetes and Endocrinology","volume":"52 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83857375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improved HbA1c value by combined treatment of Dulaglutide and Imeglimin for patient with type 2 diabetes mellitus (T2DM) 杜拉鲁肽联合依美霉素治疗2型糖尿病患者改善HbA1c值
International Journal of Diabetes and Endocrinology Pub Date : 2022-02-26 DOI: 10.36266/ijed/135
H. Bando, Iwatsuki, Sakamoto
{"title":"Improved HbA1c value by combined treatment of Dulaglutide and Imeglimin for patient with type 2 diabetes mellitus (T2DM)","authors":"H. Bando, Iwatsuki, Sakamoto","doi":"10.36266/ijed/135","DOIUrl":"https://doi.org/10.36266/ijed/135","url":null,"abstract":"Background: As a novel oral hypoglycemic agent (OHA), imeglimin has been recently applied for patients with type 2 diabetes mellitus (T2DM) as Twymeeg. It has beneficial twin mechanisms associated with increasing insulin secretion, and decreasing insulin resistance. It has a triazine ring and become the first OHA for tetrahydrotriazine-containing agent in the category of the glimins. Case presentation: The case is 84-year-old female with T2DM and mild cognitive impairment (MCI). Her HbA1c was 9.3% a year ago. Results: She was begun to receive Dulaglutide 0.75mg/week and showed 1.3% HbA1c reduction for 6 months. However, HbA1c was elevated again to 8.5%, and then she was provided Twymeeg 2000mg/day. HbA1c decreased from 8.5% to 7.5% in 3 months. [Discussion and conclusion] From combined treatments of imeglimin and other agents in the previous study, mean HbA1c reduction showed single imiglimin -0.46%, DPP-4i -0.92% and GLP-1RA -0.12%. Possible reason for the difference between the latter two suggests that multiple action mechanisms of imeglimin may be present including the enhancement of glucose-stimulated insulin secretion (GSIS). In contrast, she showed satisfactory HbA1c reduction by the combination of imeglimin and GLP-1RA. The pathophysiology is not clear, and future follow up the clinical progress will be required.","PeriodicalId":13900,"journal":{"name":"International Journal of Diabetes and Endocrinology","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77994034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Investigation for Daily Profile of Blood Glucose by the Administration of Canagliflozin and Xultophy (IdegLira) 加格列净和Xultophy (IdegLira)对每日血糖谱的影响
International Journal of Diabetes and Endocrinology Pub Date : 2022-01-12 DOI: 10.36266/ijed/129
{"title":"Investigation for Daily Profile of Blood Glucose by the Administration of Canagliflozin and Xultophy (IdegLira)","authors":"","doi":"10.36266/ijed/129","DOIUrl":"https://doi.org/10.36266/ijed/129","url":null,"abstract":"","PeriodicalId":13900,"journal":{"name":"International Journal of Diabetes and Endocrinology","volume":"48 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84820607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
A Case of Secondary Hypogonadism with Increased Risk of Fractures in a 57-year-old Male Patient on Methadone Maintenance Therapy 一位接受美沙酮维持治疗的57岁男性继发性性腺功能减退伴骨折风险增加的病例
International Journal of Diabetes and Endocrinology Pub Date : 2022-01-01 DOI: 10.11648/j.ijde.20220701.12
Mario Sebastian Campana, M. Riofrío, R. Jadav, Guido Macchiavello
{"title":"A Case of Secondary Hypogonadism with Increased Risk of Fractures in a 57-year-old Male Patient on Methadone Maintenance Therapy","authors":"Mario Sebastian Campana, M. Riofrío, R. Jadav, Guido Macchiavello","doi":"10.11648/j.ijde.20220701.12","DOIUrl":"https://doi.org/10.11648/j.ijde.20220701.12","url":null,"abstract":"","PeriodicalId":13900,"journal":{"name":"International Journal of Diabetes and Endocrinology","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89289572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Exercise and Non-exercise Interventions on Cardiac Angiogenesis in Diabetes Mellitus Patients: A Review 运动与非运动干预对糖尿病患者心脏血管生成的影响
International Journal of Diabetes and Endocrinology Pub Date : 2022-01-01 DOI: 10.11648/j.ijde.20220701.11
Reza Sabzevari Rad
{"title":"Effect of Exercise and Non-exercise Interventions on Cardiac Angiogenesis in Diabetes Mellitus Patients: A Review","authors":"Reza Sabzevari Rad","doi":"10.11648/j.ijde.20220701.11","DOIUrl":"https://doi.org/10.11648/j.ijde.20220701.11","url":null,"abstract":"","PeriodicalId":13900,"journal":{"name":"International Journal of Diabetes and Endocrinology","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77563095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Diabetic-Mellitus as an Etiological Factor in Hearing Loss 糖尿病是听力损失的一个病因
International Journal of Diabetes and Endocrinology Pub Date : 2022-01-01 DOI: 10.11648/j.ijde.20220701.13
J. Jyoti, Younus Majeed Dar, Shahnaz Ahmed Mir, I. Ali
{"title":"Diabetic-Mellitus as an Etiological Factor in Hearing Loss","authors":"J. Jyoti, Younus Majeed Dar, Shahnaz Ahmed Mir, I. Ali","doi":"10.11648/j.ijde.20220701.13","DOIUrl":"https://doi.org/10.11648/j.ijde.20220701.13","url":null,"abstract":"","PeriodicalId":13900,"journal":{"name":"International Journal of Diabetes and Endocrinology","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81720956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信